Together, these data strongly indicate that under hypoxic conditions, pancreatic tumor cells significantly upregulate the enzyme ERO1α, which is a critical determinant of pancreatic cancer patient survival. The gene discussed is ERO1A; the disease is familial pancreatic carcinoma.